![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | PRPS2 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:11168 | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of PRPS2 mRNA | CTD | PMID:22206623 | PRPS2 | Human | 17alpha-ethynylestradiol | decreases expression | ISO | RGD:3415 | 6480464 | Ethinyl Estradiol results in decreased expression of PRPS2 mRNA | CTD | PMID:15834898 | PRPS2 | Human | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | decreases expression | EXP | | 6480464 | Metribolone results in decreased expression of PRPS2 protein | CTD | PMID:17152098 | PRPS2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:11168 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PRPS2 mRNA | CTD | PMID:21570461 | PRPS2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:3415 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PRPS2 mRNA | CTD | PMID:34747641 | PRPS2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:11168 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PRPS2 mRNA | CTD | PMID:33956508 | PRPS2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:3415 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PRPS2 mRNA | CTD | PMID:32109520 | PRPS2 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of PRPS2 mRNA | CTD | PMID:21179406 | PRPS2 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | RGD:11168 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PRPS2 mRNA | CTD | PMID:26251327 | PRPS2 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | RGD:3415 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PRPS2 mRNA | CTD | PMID:30071829 | PRPS2 | Human | 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:11168 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of PRPS2 mRNA | CTD | PMID:18648102 | PRPS2 | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of PRPS2 mRNA | CTD | PMID:31121516 | PRPS2 | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:11168 | 6480464 | Fenretinide results in increased expression of PRPS2 mRNA | CTD | PMID:28973697 | PRPS2 | Human | 5-fluorouracil | decreases expression | EXP | | 6480464 | Fluorouracil results in decreased expression of PRPS2 mRNA | CTD | PMID:16510598 | PRPS2 | Human | 6-propyl-2-thiouracil | increases expression | ISO | RGD:3415 | 6480464 | Propylthiouracil results in increased expression of PRPS2 mRNA | CTD | PMID:30047161 | PRPS2 | Human | acetamide | decreases expression | ISO | RGD:3415 | 6480464 | acetamide results in decreased expression of PRPS2 mRNA | CTD | PMID:31881176 | PRPS2 | Human | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268 | PRPS2 | Human | actinomycin D | multiple interactions | EXP | | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of PRPS2 protein | CTD | PMID:38460933 | PRPS2 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of PRPS2 gene | CTD | PMID:27153756 | PRPS2 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of PRPS2 mRNA | CTD | PMID:33167477 | PRPS2 | Human | alpha-pinene | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268 | PRPS2 | Human | alpha-Zearalanol | multiple interactions | ISO | RGD:3415 | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PRPS2 mRNA | CTD | PMID:35163327 | PRPS2 | Human | amitrole | increases expression | ISO | RGD:3415 | 6480464 | Amitrole results in increased expression of PRPS2 mRNA | CTD | PMID:30047161 | PRPS2 | Human | ammonium chloride | affects expression | ISO | RGD:3415 | 6480464 | Ammonium Chloride affects the expression of PRPS2 mRNA | CTD | PMID:16483693 | PRPS2 | Human | amphetamine | decreases expression | ISO | RGD:3415 | 6480464 | Amphetamine results in decreased expression of PRPS2 mRNA | CTD | PMID:30779732 | PRPS2 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of PRPS2 mRNA | CTD | PMID:33212167 | PRPS2 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of PRPS2 protein | CTD | PMID:33212167 | PRPS2 | Human | Aroclor 1254 | decreases expression | ISO | RGD:11168 | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of PRPS2 mRNA | CTD | PMID:23650126 | PRPS2 | Human | arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to PRPS2 mRNA] | CTD | PMID:32406909 | PRPS2 | Human | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of PRPS2 protein | CTD | PMID:25419056 | PRPS2 | Human | arsenous acid | multiple interactions | EXP | | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PRPS2 protein] | CTD | PMID:26598702 | PRPS2 | Human | benzo[a]pyrene | increases expression | ISO | RGD:11168 | 6480464 | Benzo(a)pyrene results in increased expression of PRPS2 mRNA | CTD | PMID:19770486|PMID:22228805 | PRPS2 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of PRPS2 exon; Benzo(a)pyrene affects the methylation of PRPS2 promoter | CTD | PMID:27901495 | PRPS2 | Human | benzo[a]pyrene diol epoxide I | increases expression | EXP | | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PRPS2 mRNA | CTD | PMID:19150397 | PRPS2 | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PRPS2 mRNA | CTD | PMID:20018196 | PRPS2 | Human | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of PRPS2 intron | CTD | PMID:30157460 | PRPS2 | Human | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:3415 | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PRPS2 more ... | CTD | PMID:23359474 | PRPS2 | Human | bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:11168 | 6480464 | Diethylhexyl Phthalate results in decreased expression of PRPS2 mRNA | CTD | PMID:34319233 | PRPS2 | Human | bisphenol A | multiple interactions | ISO | RGD:3415 | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PRPS2 more ... | CTD | PMID:23359474 | PRPS2 | Human | bisphenol A | increases expression | ISO | RGD:3415 | 6480464 | bisphenol A results in increased expression of PRPS2 mRNA | CTD | PMID:25181051|PMID:32145629 | PRPS2 | Human | cadmium atom | multiple interactions | ISO | RGD:11168 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRPS2 more ... | CTD | PMID:37325564 | PRPS2 | Human | cadmium dichloride | multiple interactions | ISO | RGD:11168 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRPS2 more ... | CTD | PMID:37325564 | PRPS2 | Human | carbon nanotube | decreases expression | ISO | RGD:11168 | 6480464 | Nanotubes, Carbon analog results in decreased expression of PRPS2 mRNA | CTD | PMID:25620056 | PRPS2 | Human | cetrorelix | multiple interactions | EXP | | 6480464 | [cetrorelix co-treated with testosterone enanthate] results in decreased expression of PRPS2 mRNA | CTD | PMID:18160741 | PRPS2 | Human | chromium(6+) | affects expression | ISO | RGD:11168 | 6480464 | chromium hexavalent ion affects the expression of PRPS2 mRNA | CTD | PMID:28472532 | PRPS2 | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of PRPS2 mRNA | CTD | PMID:27392435|PMID:27594783 | PRPS2 | Human | clobetasol | increases expression | ISO | RGD:11168 | 6480464 | Clobetasol results in increased expression of PRPS2 mRNA | CTD | PMID:27462272 | PRPS2 | Human | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of PRPS2 mRNA | CTD | PMID:19320972 | PRPS2 | Human | copper atom | decreases expression | ISO | RGD:3415 | 6480464 | Copper results in decreased expression of PRPS2 mRNA | CTD | PMID:22465980 | PRPS2 | Human | copper atom | increases expression | ISO | RGD:3415 | 6480464 | Copper results in increased expression of PRPS2 mRNA | CTD | PMID:30556269 | PRPS2 | Human | copper(0) | decreases expression | ISO | RGD:3415 | 6480464 | Copper results in decreased expression of PRPS2 mRNA | CTD | PMID:22465980 | PRPS2 | Human | copper(0) | increases expression | ISO | RGD:3415 | 6480464 | Copper results in increased expression of PRPS2 mRNA | CTD | PMID:30556269 | PRPS2 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of PRPS2 mRNA | CTD | PMID:19549813 | PRPS2 | Human | coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of PRPS2 mRNA | CTD | PMID:19167446 | PRPS2 | Human | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of PRPS2 mRNA | CTD | PMID:19167446 | PRPS2 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of PRPS2 mRNA | CTD | PMID:20106945|PMID:25562108 | PRPS2 | Human | DDE | increases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of PRPS2 mRNA | CTD | PMID:38568856 | PRPS2 | Human | diarsenic trioxide | multiple interactions | EXP | | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PRPS2 protein] | CTD | PMID:26598702 | PRPS2 | Human | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of PRPS2 protein | CTD | PMID:25419056 | PRPS2 | Human | dibutyl phthalate | multiple interactions | ISO | RGD:3415 | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PRPS2 more ... | CTD | PMID:23359474 | PRPS2 | Human | dioxygen | multiple interactions | ISO | RGD:11168 | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of PRPS2 mRNA | CTD | PMID:30529165 | PRPS2 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | PRPS2 | Human | ethanol | decreases expression | ISO | RGD:3415 | 6480464 | Ethanol results in decreased expression of PRPS2 protein | CTD | PMID:19609968 | PRPS2 | Human | ethanol | affects splicing | ISO | RGD:11168 | 6480464 | Ethanol affects the splicing of PRPS2 mRNA | CTD | PMID:30319688 | PRPS2 | Human | fenvalerate | increases expression | ISO | RGD:3415 | 6480464 | fenvalerate results in increased expression of PRPS2 mRNA | CTD | PMID:30307764 | PRPS2 | Human | gentamycin | increases expression | ISO | RGD:3415 | 6480464 | Gentamicins results in increased expression of PRPS2 mRNA | CTD | PMID:22061828 | PRPS2 | Human | hexane | decreases methylation | ISO | RGD:3415 | 6480464 | n-hexane results in decreased methylation of PRPS2 promoter | CTD | PMID:23740543 | PRPS2 | Human | indometacin | decreases expression | ISO | RGD:3415 | 6480464 | Indomethacin results in decreased expression of PRPS2 mRNA | CTD | PMID:36868495 | PRPS2 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of PRPS2 protein | CTD | PMID:32959892 | PRPS2 | Human | kojic acid | increases expression | EXP | | 6480464 | kojic acid results in increased expression of PRPS2 mRNA | CTD | PMID:16595896 | PRPS2 | Human | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of PRPS2 intron | CTD | PMID:30157460 | PRPS2 | Human | methimazole | increases expression | ISO | RGD:3415 | 6480464 | Methimazole results in increased expression of PRPS2 mRNA | CTD | PMID:30047161 | PRPS2 | Human | methotrexate | affects expression | ISO | RGD:11168 | 6480464 | Methotrexate affects the expression of PRPS2 mRNA | CTD | PMID:18502557 | PRPS2 | Human | microcystin RR | decreases expression | EXP | | 6480464 | microcystin RR results in decreased expression of PRPS2 protein | CTD | PMID:19111056 | PRPS2 | Human | microcystin RR | increases expression | EXP | | 6480464 | microcystin RR results in increased expression of PRPS2 protein | CTD | PMID:19111056 | PRPS2 | Human | nickel atom | increases expression | ISO | RGD:11168 | 6480464 | Nickel results in increased expression of PRPS2 mRNA | CTD | PMID:18922574 | PRPS2 | Human | nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of PRPS2 mRNA | CTD | PMID:22714537 | PRPS2 | Human | nitrates | multiple interactions | ISO | RGD:11168 | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PRPS2 more ... | CTD | PMID:35964746 | PRPS2 | Human | Nutlin-3 | multiple interactions | EXP | | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of PRPS2 protein | CTD | PMID:38460933 | PRPS2 | Human | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268 | PRPS2 | Human | perfluorohexanesulfonic acid | increases expression | ISO | RGD:11168 | 6480464 | perfluorohexanesulfonic acid results in increased expression of PRPS2 mRNA | CTD | PMID:37995155 | PRPS2 | Human | perfluorooctanoic acid | decreases expression | ISO | RGD:11168 | 6480464 | perfluorooctanoic acid results in decreased expression of PRPS2 mRNA | CTD | PMID:23626681 | PRPS2 | Human | perfluorooctanoic acid | multiple interactions | ISO | RGD:3415 | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PRPS2 mRNA | CTD | PMID:35163327 | PRPS2 | Human | perfluorooctanoic acid | multiple interactions | ISO | RGD:11168 | 6480464 | Dietary Fats, Unsaturated promotes the reaction [perfluorooctanoic acid results in increased expression of PRPS2 mRNA] | CTD | PMID:23626681 | PRPS2 | Human | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of PRPS2 mRNA | CTD | PMID:26272509 | PRPS2 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | PRPS2 | Human | pirinixic acid | increases expression | ISO | RGD:3415 | 6480464 | pirinixic acid results in increased expression of PRPS2 mRNA | CTD | PMID:16940010 | PRPS2 | Human | pirinixic acid | decreases expression | ISO | RGD:11168 | 6480464 | pirinixic acid results in decreased expression of PRPS2 mRNA | CTD | PMID:23811191 | PRPS2 | Human | potassium chromate | increases expression | EXP | | 6480464 | potassium chromate(VI) results in increased expression of PRPS2 mRNA | CTD | PMID:22714537 | PRPS2 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of PRPS2 mRNA | CTD | PMID:19167446 | PRPS2 | Human | rotenone | increases expression | ISO | RGD:3415 | 6480464 | Rotenone results in increased expression of PRPS2 mRNA | CTD | PMID:28374803 | PRPS2 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | PRPS2 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of PRPS2 mRNA | CTD | PMID:22714537 | PRPS2 | Human | sodium arsenite | decreases expression | ISO | RGD:11168 | 6480464 | sodium arsenite results in decreased expression of PRPS2 mRNA | CTD | PMID:37682722 | PRPS2 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of PRPS2 mRNA | CTD | PMID:38568856 | PRPS2 | Human | sodium arsenite | increases expression | ISO | RGD:11168 | 6480464 | sodium arsenite results in increased expression of PRPS2 mRNA | CTD | PMID:16322246 | PRPS2 | Human | sodium dodecyl sulfate | decreases expression | EXP | | 6480464 | Sodium Dodecyl Sulfate results in decreased expression of PRPS2 protein | CTD | PMID:21469165 | PRPS2 | Human | sulforaphane | multiple interactions | ISO | RGD:11168 | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of PRPS2 mRNA | CTD | PMID:30529165 | PRPS2 | Human | tanespimycin | multiple interactions | EXP | | 6480464 | [tanespimycin co-treated with VER 155008] results in decreased expression of PRPS2 protein | CTD | PMID:31370342 | PRPS2 | Human | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of PRPS2 mRNA | CTD | PMID:31758290 | PRPS2 | Human | testosterone enanthate | multiple interactions | EXP | | 6480464 | [cetrorelix co-treated with testosterone enanthate] results in decreased expression of PRPS2 mRNA | CTD | PMID:18160741 | PRPS2 | Human | thioacetamide | increases expression | ISO | RGD:3415 | 6480464 | Thioacetamide results in increased expression of PRPS2 mRNA | CTD | PMID:23411599|PMID:34492290 | PRPS2 | Human | thiram | decreases expression | EXP | | 6480464 | Thiram results in decreased expression of PRPS2 mRNA | CTD | PMID:38568856 | PRPS2 | Human | trimellitic anhydride | increases expression | ISO | RGD:11168 | 6480464 | trimellitic anhydride results in increased expression of PRPS2 mRNA | CTD | PMID:19042947 | PRPS2 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of PRPS2 mRNA | CTD | PMID:37042841 | PRPS2 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of PRPS2 gene | CTD | PMID:29154799 | PRPS2 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of PRPS2 mRNA | CTD | PMID:29154799 | PRPS2 | Human | zearalenone | decreases expression | ISO | RGD:11168 | 6480464 | Zearalenone results in decreased expression of PRPS2 protein | CTD | PMID:36252740 | |